▶ 調査レポート

消化性潰瘍治療薬の世界市場

• 英文タイトル:Global Market Study on Peptic Ulcer Drugs: Increasing NSAID Consumption Boding Well for Growth of the Market

Persistence Market Researchが調査・発行した産業分析レポートです。消化性潰瘍治療薬の世界市場 / Global Market Study on Peptic Ulcer Drugs: Increasing NSAID Consumption Boding Well for Growth of the Market / PMR2009039資料のイメージです。• レポートコード:PMR2009039
• 出版社/出版日:Persistence Market Research / 2020年8月13日
• レポート形態:英文、PDF、300ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Individual User(1名用)¥514,500 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥798,000 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,113,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、消化性潰瘍治療薬の世界市場を徹底調査するとともに、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、主要成功要因、価格分析・予測、価格分析、製品別(プロトンポンプ阻害剤、カリウムイオン競合型アシッドブロッカー(P-CAB)、制酸剤、H2-拮抗薬、抗生物質)分析、疾患別(胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症(GERD))分析、流通チャネル別(病院薬局、民間クリニック、ドラッグストア、小売薬局、Eコマース)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを明らかに致します。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場背景
・主要成功要因
・価格分析・予測
・価格分析
・消化性潰瘍治療薬の世界市場規模:製品別(プロトンポンプ阻害剤、カリウムイオン競合型アシッドブロッカー(P-CAB)、制酸剤、H2-拮抗薬、抗生物質)
・消化性潰瘍治療薬の世界市場規模:疾患別(胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症(GERD))
・消化性潰瘍治療薬の世界市場規模:流通チャネル別(病院薬局、民間クリニック、ドラッグストア、小売薬局、Eコマース)
・消化性潰瘍治療薬の世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Peptic Ulcer Drugs Market – Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global peptic ulcer drugs market. The study provides detailed assessment of key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the peptic ulcer drugs market structure. The market study presents exclusive information about how the peptic ulcer drugs market will grow during the forecast period (2020-2030).

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compound annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes definitions, drivers, and opportunity analysis by region and by product, which helps in the deep understanding of the market segment details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the peptic ulcer drugs market during the forecast period.

The study is relevant for manufacturers, physicians, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researchers, shareholders, and industry experts can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to the macroeconomics factors that are impacting developments in the peptic ulcer drugs market. It also offers actionable insights based on the future trends in the peptic ulcer drugs market. Furthermore, small businesses and new entrants in the peptic ulcer drugs market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Questions Answered in PMR’s Peptic Ulcer Drugs Market Report

Which regions will continue to remain the most profitable regional markets for peptic ulcer drugs market players?
Which factors will induce a change in the demand for peptic ulcer drugs during the assessment period?
What are the different opportunities available for emerging players in the peptic ulcer drugs market?
How are supply-side and demand-side drivers impacting the peptic ulcer drugs market?
How will changing trends impact the peptic ulcer drugs market?
How can market players capture the low-hanging opportunities in the peptic ulcer drugs market in developed regions?
Which companies are leading the peptic ulcer drugs market?
What are the winning strategies of stakeholders in the peptic ulcer drugs market to upscale their position in this landscape?
Peptic Ulcer Drugs Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the peptic ulcer drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the peptic ulcer drugs market study include statistics from government healthcare organizations, medicines journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the peptic ulcer drugs market, and makes PMR’s projections on the growth prospects of the peptic ulcer drugs market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.2. Forecast Factors – Relevance & Impact

4.3. Current COVID19 Statistics and Probable Future Impact

4.3.1. Current COVID19 Statistics and Probable Future Impact

4.3.2. Current GDP Projection and Probable Impact

4.3.3. Current Economic Projection as compared to 2008 Economic analysis

4.3.4. COVID19 and Impact Analysis

4.3.4.1. Revenue By Product

4.3.4.2. Revenue By Indication

4.3.4.3. Revenue By Distribution Channel

4.3.5. 2020 Market Scenario

4.3.6. Quarter by Quarter Forecast

4.3.7. Projected recovery Quarter

4.3.8. Recovery Scenario – Short term, Midterm and Long Term Impact

4.4. Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunities

5. Key Success Factors

5.1. Product USPs/ Features

5.2. Product Adoption / Usage Analysis

5.3. Epidemiology Scenario

5.4. Reimbursement Scenario

5.5. Regulatory Landscape

6. Global Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Opportunity Analysis, 2020-2030

7. Global Disposable Blood Bags Replacement Market – Pricing Analysis

7.1. Regional Pricing Analysis By Collection Bags

7.2. Pricing Break-up

7.2.1. Manufacturer Level Pricing

7.2.2. Distributor Level Pricing

7.3. Global Average Pricing Analysis Benchmark

8. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, By Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2019

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030

8.3.1. Proton Pump Inhibitors

8.3.2. Potassium-Competitive Acid Blocker (P-CAB)

8.3.3. Antacids

8.3.4. H2- Antagonists

8.3.5. Antibiotics

8.3.6. Ulcer Protective

8.4. Market Attractiveness Analysis By Product

9. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2019

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030

9.3.1. Gastritis

9.3.2. Gastric Ulcer

9.3.3. Duodenal Ulcer

9.3.4. Gastroesophageal Reflux Disease (GERD)

9.4. Market Attractiveness Analysis By Indication

10. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030

10.3.1. Hospital Pharmacies

10.3.2. Private Clinics

10.3.3. Drug Stores

10.3.4. Retail Pharmacies

10.3.5. E-Commerce

10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, by Region

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa

11.4. Market Attractiveness Analysis By Region

12. North America Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Product

12.3.3. By Indication

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Product

13.3.3. By Indication

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Product

14.3.3. By Indication

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Product

15.3.3. By Indication

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Product

16.3.3. By Indication

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Product

17.3.3. By Indication

17.3.4. By Distribution Channel

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. By Product

18.3.3. By Indication

18.3.4. By Distribution Channel

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Key and Emerging Countries Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. U.S. Peptic Ulcer Drugs Market Analysis

19.2.1. By Product

19.2.2. By Indication

19.2.3. By Distribution Channel

19.3. Canada Peptic Ulcer Drugs Market Analysis

19.3.1. By Product

19.3.2. By Indication

19.3.3. By Distribution Channel

19.4. Mexico Peptic Ulcer Drugs Market Analysis

19.4.1. By Product

19.4.2. By Indication

19.4.3. By Distribution Channel

19.5. Brazil Peptic Ulcer Drugs Market Analysis

19.5.1. By Product

19.5.2. By Indication

19.5.3. By Distribution Channel

19.6. U.K. Peptic Ulcer Drugs Market Analysis

19.6.1. By Product

19.6.2. By Indication

19.6.3. By Distribution Channel

19.7. Germany Peptic Ulcer Drugs Market Analysis

19.7.1. By Product

19.7.2. By Indication

19.7.3. By Distribution Channel

19.8. France Peptic Ulcer Drugs Market Analysis

19.8.1. By Product

19.8.2. By Indication

19.8.3. By Distribution Channel

19.9. Italy Peptic Ulcer Drugs Market Analysis

19.9.1. By Product

19.9.2. By Indication

19.9.3. By Distribution Channel

19.10. Spain Peptic Ulcer Drugs Market Analysis

19.10.1. By Product

19.10.2. By Indication

19.10.3. By Distribution Channel

19.11. BENELUX Peptic Ulcer Drugs Market Analysis

19.11.1. By Product

19.11.2. By Indication

19.11.3. By Distribution Channel

19.12. Russia Peptic Ulcer Drugs Market Analysis

19.12.1. By Product

19.12.2. By Indication

19.12.3. By Distribution Channel

19.13. China Peptic Ulcer Drugs Market Analysis

19.13.1. By Product

19.13.2. By Indication

19.13.3. By Distribution Channel

19.14. Japan Peptic Ulcer Drugs Market Analysis

19.14.1. By Product

19.14.2. By Indication

19.14.3. By Distribution Channel

19.15. South Korea Peptic Ulcer Drugs Market Analysis

19.15.1. By Product

19.15.2. By Indication

19.15.3. By Distribution Channel

19.16. India Peptic Ulcer Drugs Market Analysis

19.16.1. By Product

19.16.2. By Indication

19.16.3. By Distribution Channel

19.17. ASEAN Peptic Ulcer Drugs Market Analysis

19.17.1. By Product

19.17.2. By Indication

19.17.3. By Distribution Channel

19.18. Australia Peptic Ulcer Drugs Market Analysis

19.18.1. By Product

19.18.2. By Indication

19.18.3. By Distribution Channel

19.19. New Zealand Peptic Ulcer Drugs Market Analysis

19.19.1. By Product

19.19.2. By Indication

19.19.3. By Distribution Channel

19.20. GCC Countries Peptic Ulcer Drugs Market Analysis

19.20.1. By Product

19.20.2. By Indication

19.20.3. By Distribution Channel

19.21. Turkey Peptic Ulcer Drugs Market Analysis

19.21.1. By Product

19.21.2. By Indication

19.21.3. By Distribution Channel

19.22. South Africa Peptic Ulcer Drugs Market Analysis

19.22.1. By Product

19.22.2. By Indication

19.22.3. By Distribution Channel

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players

20.3. Market Presence Analysis

20.3.1. Regional Footprint by Players

20.3.2. Product Foot print by Players

20.3.3. Channel Foot Print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive (Tentative List)

21.3.1. Pfizer Inc.

21.3.1.1. Overview

21.3.1.2. Product Portfolio

21.3.1.3. Sales Footprint

21.3.1.4. Analyst commentary

21.3.2. Abbvie Inc.

21.3.2.1. Overview

21.3.2.2. Product Portfolio

21.3.2.3. Sales Footprint

21.3.2.4. Analyst commentary

21.3.3. GlaxoSmithKline plc.

21.3.3.1. Overview

21.3.3.2. Product Portfolio

21.3.3.3. Sales Footprint

21.3.3.4. Analyst commentary

21.3.4. AstraZeneca plc

21.3.4.1. Overview

21.3.4.2. Product Portfolio

21.3.4.3. Sales Footprint

21.3.4.4. Analyst commentary

21.3.5. Boehringer Ingelheim GmbH

21.3.5.1. Overview

21.3.5.2. Product Portfolio

21.3.5.3. Sales Footprint

21.3.5.4. Analyst commentary

21.3.6. Daewoong Pharmaceutical Co., Ltd.

21.3.6.1. Overview

21.3.6.2. Product Portfolio

21.3.6.3. Sales Footprint

21.3.6.4. Analyst commentary

21.3.7. Takeda Pharmaceutical

21.3.7.1. Overview

21.3.7.2. Product Portfolio

21.3.7.3. Sales Footprint

21.3.7.4. Analyst commentary

21.3.8. Eisai Co. Ltd.

21.3.8.1. Overview

21.3.8.2. Product Portfolio

21.3.8.3. Sales Footprint

21.3.8.4. Analyst commentary

21.3.9. Cadila Healthcare Ltd.

21.3.9.1. Overview

21.3.9.2. Product Portfolio

21.3.9.3. Sales Footprint

21.3.9.4. Analyst commentary

21.3.10. Yuhan Corporation

21.3.10.1. Overview

21.3.10.2. Product Portfolio

21.3.10.3. Sales Footprint

21.3.10.4. Analyst commentary

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables:

Table 01: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 02: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 03: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

Table 04: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Region

Table 05: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 06: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 07: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 08: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

Table 09: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 10: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 11: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 12: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

Table 13: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 14: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 15: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 16: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

Table 17: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 18: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 19: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 20: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

Table 21: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 22: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 23: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 24: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

Table 25: Oceania Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 26: Oceania Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 27: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country

Table 28: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product

Table 29: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication

Table 30: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel